Synthetic biology startup manufacturing alternative proteins via precision fermentation.
| Date | Round | Amount |
|---|---|---|
| May 2026 | Funding round StrainX Bioworks came out of stealth with $13M co-led by Prime Venture Partners and Leo Capital for the production of alternative proteins. | $13M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.